Search - tctmd.com

Displaying 521 - 540 of 891

Sort: Relevancy | Date

Presentation TCT 2013

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

Challenging Reimbursement Considerations for TAVR in the United States

Presenter: Wilson Szeto

October 28, 2013

Presentation TCT 2013

Case Presentation: TAVR in a Moderate Risk Aortic Stenosis Patient

Presenter: Alexey Protopopov

October 28, 2013

Presentation TCT 2013

Case Examples(9)

Presenter: Ardawan Rastan

October 28, 2013

Presentation TCT 2013

Case Examples(8)

Presenter: Simon Redwood

October 28, 2013

Presentation TCT 2013

Case Examples(7)

Presenter: Ganesh Manoharan

October 28, 2013

Presentation TCT 2013

Case Examples(6)

Presenter: Ted Feldman

October 28, 2013

Presentation TCT 2013

Case Examples(5)

Presenter: Antonio Colombo

October 28, 2013

Presentation TCT 2013

Case Examples(4)

Presenter: Sanjeevan Pasupati

October 28, 2013

Presentation TCT 2013

Case Examples(3)

Presenter: Axel Linke

October 28, 2013

Presentation TCT 2013

Case Examples(2)

Presenter: Joerg Kempfert

October 28, 2013

Presentation TCT 2013

Case Examples

Presenter: David Wood

October 28, 2013

Presentation TCT 2013

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Presenter: Hans Figulla

October 28, 2013

Presentation TCT 2013

Canada

Presenter: John Webb

October 28, 2013

Presentation TCT 2013

But "May" Also Increase Strokes

Presenter: Henrique Ribeiro

October 28, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation TCT 2013

Annulus Sizing Using MSCT Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Jonathon Leipsic

October 28, 2013

Presentation TCT 2013

And Should Also Be Based on Hemodynamic Assessments: The Dimensionless AR Index

Presenter: Jan Kovac

October 28, 2013

Presentation TCT 2013

Anatomical and Procedural Features of Aortic Root Rupture During TAVR: A Multicenter Report

Presenter: Marco Barbanti

October 28, 2013

Presentation TCT 2013

ACURATE TF: Technology, Clinical Results, and Case Examples

Presenter: Helge Moellmann

October 28, 2013

Advertisement

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Challenging Reimbursement Considerations for TAVR in the United States

Case Presentation: TAVR in a Moderate Risk Aortic Stenosis Patient

Case Examples(9)

Case Examples(8)

Case Examples(7)

Case Examples(6)

Case Examples(5)

Case Examples(4)

Case Examples(3)

Case Examples(2)

Case Examples

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Canada

But "May" Also Increase Strokes

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Annulus Sizing Using MSCT Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

And Should Also Be Based on Hemodynamic Assessments: The Dimensionless AR Index

Anatomical and Procedural Features of Aortic Root Rupture During TAVR: A Multicenter Report

ACURATE TF: Technology, Clinical Results, and Case Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content